Operating
Other Working Capital
Eli Lilly Other Working Capital decreased by 157.9% to -$175.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 136.9%, from $474.00M to -$175.00M. Over 2 years (FY 2021 to FY 2023), Other Working Capital shows a downward trend with a -33.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Large fluctuations may indicate timing differences in tax payments, accruals, or other non-core operational shifts.
Detailed definition
Captures the net impact of changes in operating assets and liabilities not categorized as accounts receivable, inventory...
Peer comparison
Varies significantly by industry; peers with similar business models should show comparable trends in accrual management.
Metric ID:
change_in_other_working_capitalHistorical Data
16 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $188.50M | $185.10M | $222.70M | $32.60M | -$81.80M | $361.30M | $149.20M | $168.30M | -$550.70M | $485.60M | $215.80M | $298.60M | $662.30M | $474.00M | $302.30M | -$175.00M |
| QoQ Change | — | -1.8% | +20.3% | -85.4% | -350.9% | +541.7% | -58.7% | +12.8% | -427.2% | +188.2% | -55.6% | +38.4% | +121.8% | -28.4% | -36.2% | -157.9% |
| YoY Change | — | — | — | — | -143.4% | +95.2% | -33.0% | +416.3% | -573.2% | +34.4% | +44.6% | +77.4% | +206.9% | +58.7% | — | -136.9% |
Range-$550.70M – $662.30M
CAGR-2.0%
Avg YoY Growth+4.3%
Median YoY Growth+44.6%
Current Streak3 quarters decline
Other Working Capital at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other working capital?
- Eli Lilly (LLY) reported other working capital of -$175.00M in Q1 2026.
- How has Eli Lilly's other working capital changed year-over-year?
- Eli Lilly's other working capital decreased by 136.9% year-over-year, from $474.00M to -$175.00M.
- What is the long-term trend for Eli Lilly's other working capital?
- Over 2 years (2021 to 2023), Eli Lilly's other working capital has grown at a -33.8% compound annual growth rate (CAGR), from $727.40M to $319.00M.
- What does other working capital mean?
- Net cash impact from changes in miscellaneous operating assets and liabilities.